EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Selective inhibition of ELFN2-containing PP1 hinders autophagy and enhances temozolomide sensitivity in glioblastoma

Haijuan Fu, Wei Gao, Anbo Gao, Kun Deng, Danyang Li, Jianliang Huang, Xiangyu Wang, Bing Wang, Minghua Wu

Cancer Letters · 2026-10 · 657 · 218667

DOI: 10.1016/j.canlet.2026.218667 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Letters, 2026-10. Verfasst von Haijuan Fu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Research Center, The Second Affiliated Hospital, University of South China, Hengyang, Hunan, 421001, China; Hengyang Medical S…. Hauptthemen laut MEDLINE: Temozolomide, Glioblastoma, Autophagy, Drug Resistance, Neoplasm. Die Arbeit nennt 105 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Key Project of Research and Development Plan of Hunan Province, Health Commission of Hunan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TemozolomideGlioblastomaAutophagyDrug Resistance, NeoplasmBrain NeoplasmsProtein Phosphatase 1Transcription FactorsHumansAnimalsCell Line, TumorAntineoplastic Agents, AlkylatingMicePhosphorylationVorinostatRNA-Binding ProteinsXenograft Model Antitumor AssaysRNA, Long NoncodingAlternative Splicing

Stichwörter der Autor:innen

Alternative splicingAutophagyELFN2-Containing PP1GlioblastomaTemozolomide resistant

Substanzen

TemozolomideProtein Phosphatase 1Antineoplastic Agents, AlkylatingVorinostatRNA-Binding ProteinsRNA, Long NoncodingTranscription Factors

Autor:innen und Institutionen

  • Department of Clinical Research Center, The Second Affiliated Hospital, University of South China, Hengyang, Hunan, 421001, China; Hengyang Medical School, University of South China, Hengyang, Hunan, 421001, China; The…
  • The Key Laboratory of Carcinogenesis of the Chinese Ministry of Health, the Key, Laboratory of Carcinogenesis and Cancer Invasion of the Chinese Ministry of Education, Cancer Research Institute, Central South University…
  • Department of Clinical Research Center, The Second Affiliated Hospital, University of South China, Hengyang, Hunan, 421001, China; Hengyang Medical School, University of South China, Hengyang, Hunan, 421001, China.
  • Department of Neurosurgery, Xiangya Hospital, Central South University, Changsha, China.
  • Department of Clinical Research Center, The Second Affiliated Hospital, University of South China, Hengyang, Hunan, 421001, China; Hengyang Medical School, University of South China, Hengyang, Hunan, 421001, China. Elec…

Förderung

  • National Natural Science Foundation of China
  • Key Project of Research and Development Plan of Hunan Province
  • Health Commission of Hunan Province
  • Hunan Provincial Natural Science Foundation

Zitieren

APA

Fu, H., Gao, W., Gao, A., Deng, K., Li, D., Huang, J., Wang, X., Wang, B., & Wu, M. (2026). Selective inhibition of ELFN2-containing PP1 hinders autophagy and enhances temozolomide sensitivity in glioblastoma. Cancer Letters, 657, 218667. https://doi.org/10.1016/j.canlet.2026.218667

Vancouver

Fu H, Gao W, Gao A, Deng K, Li D, Huang J, et al. Selective inhibition of ELFN2-containing PP1 hinders autophagy and enhances temozolomide sensitivity in glioblastoma. Cancer Letters. 2026;657:218667. doi:10.1016/j.canlet.2026.218667

BibTeX
@article{Fu2026,
  author = {Fu, Haijuan and Gao, Wei and Gao, Anbo and Deng, Kun and Li, Danyang and Huang, Jianliang and Wang, Xiangyu and Wang, Bing and Wu, Minghua},
  title = {Selective inhibition of ELFN2-containing PP1 hinders autophagy and enhances temozolomide sensitivity in glioblastoma},
  journal = {Cancer Letters},
  year = {2026},
  volume = {657},
  pages = {218667},
  doi = {10.1016/j.canlet.2026.218667}
}
Kostenlos starten →